Chromium (III) acetate
Chromium (III) acetate (Chromic acetate) is an AMPK inhibitor that promotes lipogenesis by inhibiting AMPK phosphorylation. Chromium (III) acetate has low toxicity in mammals, with an LD50 of 2365 mg/kg in rats[1][2].
Product Specifications
CAS Number
1066-30-4
Product Name Alternative
Chromium acetate; Chromic acetate; Chromium triacetate
UNSPSC
12352300
Hazard Statement
H302, H315, H317, H319, H332, H335, H373
Target
AMPK
Type
Reference compound
Related Pathways
Epigenetics; PI3K/Akt/mTOR
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/chromium-iii-acetate.html
Purity
99.9
Solubility
DMSO : 14.29 mg/mL (ultrasonic)
Smiles
C[Cr](C)C.O=C=O.O=C=O.O=C=O
Molecular Formula
C6H9CrO6
Molecular Weight
229.13
Precautions
H302, H315, H317, H319, H332, H335, H373
References & Citations
[1]Mahsa Baghban Salehi, et al. Rheological and transport properties of sulfonated polyacrylamide hydrogels for water shutoff in porous media. Polym. Adv. Technol. 2014, 25 396-405.|[2]Kim J, et al. Chromium acetate stimulates adipogenesis through regulation of gene expression and phosphorylation of adenosine monophosphate-activated protein kinase in bovine intramuscular or subcutaneous adipocytes[J]. Asian-Australasian journal of animal sciences, 2020, 33 (4) : 651.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH031068-01 100 µg
Recombinant Human Neuregulin-1/NRG1-β1 Protein (EGF Domain, Fc Tag)
Sign In for Pricing
View Details PKSH031068-02 1 mg
Recombinant Human Neuregulin-1/NRG1-β1 Protein (EGF Domain, Fc Tag)
Sign In for Pricing
View Details 
